{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:28:33Z","timestamp":1792452513521,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T00:00:00Z","timestamp":1758412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022230","name":"Princess Nourah bint Abdulrahman University Deanship of Scientific Research","doi-asserted-by":"publisher","award":["PNURSP2025R484"],"award-info":[{"award-number":["PNURSP2025R484"]}],"id":[{"id":"10.13039\/501100022230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004242","name":"Princess Nourah Bint Abdulrahman University","doi-asserted-by":"publisher","award":["HA-01-R-104"],"award-info":[{"award-number":["HA-01-R-104"]}],"id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jgar.2025.09.009","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:38:02Z","timestamp":1758706682000},"page":"147-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Antimicrobial utilization among hospitalized patients according to WHO AWaRe classification: Results from a multicentre point prevalence survey in Saudi Arabia"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7743-0699","authenticated-orcid":false,"given":"Nada A.","family":"Alsaleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"AlSmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrar F.","family":"Alhameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed O.","family":"Alenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa A.","family":"Alsharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2066-7190","authenticated-orcid":false,"given":"Amal","family":"Bin Akresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar M.","family":"Alnakhli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashaier","family":"Alshehail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman A.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7807-4470","authenticated-orcid":false,"given":"Ghadah H.","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazwa B.","family":"Korayem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1156-2511","authenticated-orcid":false,"given":"Hanan A.","family":"Bakri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Eljaaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina I.","family":"Alnajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah S.","family":"Aldeghaither","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Almahasna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Almuhisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassmin","family":"Alsomali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zikria","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2025.09.009_bib0001","unstructured":"World Health Organization. Antimicrobial resistance. 2021. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance [accessed 16.10.2023]."},{"key":"10.1016\/j.jgar.2025.09.009_bib0002","unstructured":"United Nations Environment Programme. Bracing for superbugs: strengthening environmental action in the one health response to antimicrobial resistance. Geneva, 2023. https:\/\/www.unep.org\/resources\/superbugs\/environmental-action [accessed 18.10.2024]."},{"key":"10.1016\/j.jgar.2025.09.009_bib0003","unstructured":"O\u2019Neill J. Tackling drug-resistant infections globally: final report and recommendations. 2016. https:\/\/amr-review.org\/ [accessed 16.10.2023]."},{"key":"10.1016\/j.jgar.2025.09.009_bib0004","unstructured":"World Health Organization. Global action plan on antimicrobial resistance. 2016. https:\/\/www.who.int\/publications\/i\/item\/9789241509763 [accessed 16.10.2023]."},{"key":"10.1016\/j.jgar.2025.09.009_bib0005","unstructured":"Saudi Arabia Ministry of Health. WHO publishes the Saudi National Action Plan for combating antimicrobial-resistant bacteria on its portal. 2017. https:\/\/www.moh.gov.sa\/en\/Ministry\/MediaCenter\/News\/Pages\/News-2017-11-19-002.aspx [accessed 16.10.2023]."},{"key":"10.1016\/j.jgar.2025.09.009_bib0006","unstructured":"World Health Organization. Kingdom of Saudi Arabia: national action plan on combating antimicrobial resistance. 2017. https:\/\/www.who.int\/publications\/m\/item\/kingdom-of-saudi-arabia-national-action-plan-on-combating-antimicrobial-resistance [accessed 16.10.2023]."},{"key":"10.1016\/j.jgar.2025.09.009_bib0007","unstructured":"World Health Organization. Kingdom of Saudi Arabia: second antimicrobial resistance action plan 2022\u20132025. 2022. https:\/\/www.who.int\/publications\/m\/item\/kingdom-of-saudi-arabia\u2013second-antimicrobial-resistance-action-plan-2022-2025 [accessed 18.10.2024]."},{"key":"10.1016\/j.jgar.2025.09.009_bib0008","unstructured":"Saudi Vision 2030. Health sector transformation program. 2024. https:\/\/www.vision2030.gov.sa\/en\/explore\/programs\/health-sector-transformation-program [accessed 18.10.2024]."},{"key":"10.1016\/j.jgar.2025.09.009_bib0009","unstructured":"World Health Organization. Aware classification of antimicrobials for evaluation and monitoring of use. 2023. https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2023.04 [accessed 16.10.2023]."},{"key":"10.1016\/j.jgar.2025.09.009_bib0010","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.cmi.2022.08.009","article-title":"The WHO essential medicines list AWaRe book: from a list to a quality improvement system","volume":"28","author":"Sharland","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2025.09.009_bib0011","unstructured":"United Nations. UN General Assembly high-level meeting on antimicrobial resistance 2024. https:\/\/www.un.org\/pga\/wp-content\/uploads\/sites\/108\/2024\/09\/FINAL-Text-AMR-to-PGA.pdf [accessed 22.03.2025]."},{"key":"10.1016\/j.jgar.2025.09.009_bib0012","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.3390\/microorganisms11082086","article-title":"An overview of antimicrobial resistance in Saudi Arabia (2013\u20132023) and the need for national surveillance","volume":"11","author":"Thabit","year":"2023","journal-title":"Microorganisms"},{"key":"10.1016\/j.jgar.2025.09.009_bib0013","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.jsps.2020.09.015","article-title":"Evaluating the appropriateness of carbapenem and piperacillin-tazobactam prescribing in a tertiary care hospital in Saudi Arabia","volume":"28","author":"Alsaleh","year":"2020","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.jgar.2025.09.009_bib0014","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/antibiotics10040366","article-title":"Exploring physicians\u2019 views, perceptions and experiences about broad-spectrum antimicrobial prescribing in a tertiary care hospital, Riyadh, Saudi Arabia: a qualitative approach","volume":"10","author":"Alsaleh","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.jgar.2025.09.009_bib0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jiph.2018.09.003","article-title":"Point prevalence survey of antibiotic use in 26 Saudi hospitals in 2016","volume":"12","author":"Al Matar","year":"2019","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jgar.2025.09.009_bib0016","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4314\/tjpr.v19i2.23","article-title":"A prospective antibiotic point prevalence survey in two primary referral hospitals during and after pilgrims\u2019 stay in Madinah, Saudi Arabia","volume":"19","author":"Alahmadi","year":"2020","journal-title":"Trop J Pharm Res"},{"key":"10.1016\/j.jgar.2025.09.009_bib0017","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3390\/antibiotics12111609","article-title":"Point prevalence survey of antimicrobial use and resistance during the COVID-19 era among hospitals in Saudi Arabia and the implications","volume":"12","author":"Haseeb","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.jgar.2025.09.009_bib0018","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/ijerph19010254","article-title":"Antimicrobial usage and resistance in Makkah Region hospitals: a regional point prevalence survey of public hospitals","volume":"19","author":"Haseeb","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jgar.2025.09.009_bib0019","doi-asserted-by":"crossref","DOI":"10.1080\/20523211.2024.2371411","article-title":"Point prevalence survey of antibiotics use among hospitalised neonates and children in Saudi Arabia: findings and implications","volume":"17","author":"Alosaimi","year":"2024","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.jgar.2025.09.009_bib0020","unstructured":"Global-PPS. Protocol Global-PPS with optional HAI module. https:\/\/www.global-pps.com\/wp-content\/uploads\/2022\/02\/Protocol-Global-PPS-with-optional-HAI-module_Feb2022.pdf [accessed 16.10.2023]."},{"key":"10.1016\/j.jgar.2025.09.009_bib0021","series-title":"National antimicrobial therapy guidelines for community and hospital acquired infections in adults","year":"2019"},{"key":"10.1016\/j.jgar.2025.09.009_bib0022","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(17)30724-7","article-title":"Classifying antibiotics in the WHO essential medicines list for optimal use \u2013 be AWaRe","volume":"18","author":"Sharland","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2025.09.009_bib0023","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jgar.2025.09.009_bib0024","first-page":"277","article-title":"Healthcare-associated infections and the use of antibiotics in German hospitals \u2013 results of the point prevalence survey of 2022 and comparison with earlier findings","volume":"121","author":"Aghdassi","year":"2024","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jgar.2025.09.009_bib0025","series-title":"Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2022\u20132023","year":"2024"},{"key":"10.1016\/j.jgar.2025.09.009_bib0026","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3390\/medicina59071237","article-title":"Using culture sensitivity reports to optimize antimicrobial therapy: findings and implications of antimicrobial stewardship activity in a hospital in Pakistan","volume":"59","author":"Altaf","year":"2023","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.jgar.2025.09.009_bib0027","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jhin.2023.10.006","article-title":"Appropriateness of acute-care antibiotic prescriptions for community-acquired infections and surgical antibiotic prophylaxis in England: analysis of 2016 national point prevalence survey data","volume":"142","author":"Higgins","year":"2023","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jgar.2025.09.009_bib0028","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1473-3099(20)30332-7","article-title":"Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000\u201315: an analysis of pharmaceutical sales data","volume":"21","author":"Klein","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2025.09.009_bib0029","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1093\/jac\/dkab050","article-title":"Hospital antibiotic prescribing patterns in adult patients according to the WHO access, watch and reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries","volume":"76","author":"Pauwels","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2025.09.009_bib0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.53806","article-title":"Association between antimicrobial stewardship programs and antibiotic use globally: a systematic review and meta-analysis","volume":"6","author":"Zay Ya","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jgar.2025.09.009_bib0031","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S1473-3099(17)30325-0","article-title":"Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and clostridium difficile infection: a systematic review and meta-analysis","volume":"17","author":"Baur","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2025.09.009_bib0032","article-title":"Continued intravenous versus first week transition to oral antibiotic therapy in bloodstream infections: a systematic review and meta-analysis","volume":"16","author":"Mohammed","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jgar.2025.09.009_bib0033","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jgar.2024.07.013","article-title":"Systematic review and meta-analysis on antimicrobial resistance and drug resistance in Saudi Arabia","volume":"39","author":"Kiran","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2025.09.009_bib0034","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/antibiotics10020193","article-title":"Antimicrobial stewardship programmes in Saudi hospitals: evidence from a national survey","volume":"10","author":"Alghamdi","year":"2021","journal-title":"Antibiotics"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716525002127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716525002127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T22:04:59Z","timestamp":1780783499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716525002127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":34,"alternative-id":["S2213716525002127"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2025.09.009","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial utilization among hospitalized patients according to WHO AWaRe classification: Results from a multicentre point prevalence survey in Saudi Arabia","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2025.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}